Contact Us

Multiple Myeloma is a form of cancer formed by malignant plasma cells. Malignant tumors are formed from highly unstable abnormal cells travelling via the blood stream, circulatory system, and lymphatic system. The plasma cells become cancerous and vigorously proliferative, producing tumor called plasmacytoma that prevents the bone marrow from producing healthy blood cells and immunoglobulins. The formation and proliferation of myeloma cells result in fewer leukocyte, erythrocyte, and platelet cell formation causing a damaged immune system. Gastrointestinal problems, enlarged organs, kidney damage, rapid weight loss, bone pain, and fever are some of the common symptoms of multiple myeloma. Multiple myeloma is considered to be the third most common blood cancer followed by lymphoma and leukemia.

Introduction of monoclonal antibodies with safety profile to fight myeloma cells is expected to drive the multiple myeloma drugs market

The increasing microRNA therapeutics, nanomedicine platform emergence, and constant introduction of effective and safe therapeutics drives the growth of multiple myeloma drugs market. The drugs market is expected to gain momentum with the addition of monoclonal antibodies and Histone Deacetylase (HDAC) inhibitors to the current therapeutics array. The biologic therapy of monoclonal antibodies including DARZALEX and EMPLICITI are largely preferred by the physicians owing to the established clinical profile. The growing prevalence of the disorder with the surging elderly population, the inefficiency of the current medication augments to invest in research and development, thereby driving the global market in the forecast period.  Additionally, the supportive treatment demand for restoration procedures including point of care technologies, approved safety profile and efficiency of monoclonal antibodies is expected to broaden the drug treatment received by the patients.

Novel targeted therapy segment is expected to fuel the multiple myeloma drugs market

The global multiple myeloma drugs market is segmented on the basis of technology, diagnosis, surgery, end user and geography.

On the basis of drug type, the global multiple myeloma drugs market is segmented into:

  • Immunomodulating agents
  • Proteasome inhibitors
  • Histone Deacetylase (HDAC) inhibitors
  • Steroids (Corticosteroids)
  • Monoclonal antibodies

On the basis of distribution channel, the global multiple myeloma drugs market is segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • ePharmacies

Presence of major key players accounts for the drastic dominance of Europe in the global multiple myeloma drugs market

Regional segmentation of the global mouth ulcers treatment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, The Middle East and Africa. According to the American Cancer Society’s estimates for 2017, about 30,280 new cases will be diagnosed including 17,490 in men and 12,790 in women in the U.S., with an expected 12,590 deaths, thus indicating rising prevalence of multiple myeloma cases in North America with the rise in effective treatment. Also, North America is expected to dominate the multiple myeloma drugs market owing to change in lifestyle habits, obesity, and the launch of various multiple myeloma therapies. For instance, the launch of NINLARO, DARZALEX, and FARYDAK will considerably drive the growth of the market in the forecast period. The European market is expected to rise drastically owing to the presence of major players, favorable reimbursement policies. and immediate FDA drug approval rates.

Launching drugs due to high unmet medical needs of patients is a strategy adopted by key players

Key players operating the global multiple myeloma drugs market include NovartisJohnson & JohnsonElgene, Takeda Pharmaceuticals, and Amgen. The strategies adopted by the key players include advances in research activities, the launch of novel therapies specific for effective treatment due to unmet medical needs increase the competition among vendors. Other leading vendors include Acceleron Pharma, Bristol-Meyer Squibb, Sanofi, GlaxoSmithKline, and Merck.


Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users